These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 29332180)
1. CD39-adenosinergic axis in renal pathophysiology and therapeutics. Kishore BK; Robson SC; Dwyer KM Purinergic Signal; 2018 Jun; 14(2):109-120. PubMed ID: 29332180 [TBL] [Abstract][Full Text] [Related]
2. The impact of purinergic signaling on renal ischemia-reperfusion injury. Lu B; Rajakumar SV; Robson SC; Lee EK; Crikis S; d'Apice AJ; Cowan PJ; Dwyer KM Transplantation; 2008 Dec; 86(12):1707-12. PubMed ID: 19104409 [TBL] [Abstract][Full Text] [Related]
3. The role of the CD39-CD73-adenosine pathway in liver disease. Wang S; Gao S; Zhou D; Qian X; Luan J; Lv X J Cell Physiol; 2021 Feb; 236(2):851-862. PubMed ID: 32648591 [TBL] [Abstract][Full Text] [Related]
4. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease. Dwyer KM; Kishore BK; Robson SC Nat Rev Nephrol; 2020 Sep; 16(9):509-524. PubMed ID: 32641760 [TBL] [Abstract][Full Text] [Related]
5. The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain. Matyash M; Zabiegalov O; Wendt S; Matyash V; Kettenmann H PLoS One; 2017; 12(4):e0175012. PubMed ID: 28376099 [TBL] [Abstract][Full Text] [Related]
6. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate. Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184 [TBL] [Abstract][Full Text] [Related]
7. Extracellular ATP inhibits IL-1-induced MMP-1 expression through the action of CD39/nucleotidase triphosphate dephosphorylase-1 on human gingival fibroblasts. Nemoto E; Gotoh K; Tsuchiya M; Sakisaka Y; Shimauchi H Int Immunopharmacol; 2013 Nov; 17(3):513-8. PubMed ID: 23941770 [TBL] [Abstract][Full Text] [Related]
8. Extracellular generation of adenosine by the ectonucleotidases CD39 and CD73 promotes dermal fibrosis. Fernández P; Perez-Aso M; Smith G; Wilder T; Trzaska S; Chiriboga L; Franks A; Robson SC; Cronstein BN; Chan ESL Am J Pathol; 2013 Dec; 183(6):1740-1746. PubMed ID: 24266925 [TBL] [Abstract][Full Text] [Related]
10. Role of extracellular ATP metabolism in regulation of platelet reactivity. Birk AV; Broekman MJ; Gladek EM; Robertson HD; Drosopoulos JH; Marcus AJ; Szeto HH J Lab Clin Med; 2002 Sep; 140(3):166-75. PubMed ID: 12271274 [TBL] [Abstract][Full Text] [Related]
11. The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injury. Roberts V; Lu B; Rajakumar S; Cowan PJ; Dwyer KM Purinergic Signal; 2013 Jun; 9(2):135-43. PubMed ID: 23188420 [TBL] [Abstract][Full Text] [Related]
12. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis. Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325 [TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury. Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235 [TBL] [Abstract][Full Text] [Related]
14. Crowding within synaptic junctions influences the degradation of nucleotides by CD39 and CD73 ectonucleotidases. Rahmaninejad H; Pace T; Chun BJ; Kekenes-Huskey PM Biophys J; 2022 Jan; 121(2):309-318. PubMed ID: 34922916 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease. Geraghty NJ; Watson D; Sluyter R Immunol Cell Biol; 2019 Jul; 97(6):597-610. PubMed ID: 30957314 [TBL] [Abstract][Full Text] [Related]